Treatment of diabetes type 1 using GLP-1 and anti-IL-21
- 专利权人:
- Novo Nordisk A/S
- 发明人:
- Ken Coppieters,Matthias von Herrath,Tamar Boursalian
- 申请号:
- US15307592
- 公开号:
- US10105442B2
- 申请日:
- 2015.05.05
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要:
- The present invention relates to use of a GLP-1 agonist and an anti-IL-2 antibody in treatment and/or prevention of type 1 diabetes.
- 来源网站:
- 中国工程科技知识中心